Acquisitions Help Drive Gen-Probe's Q1 Revenues Up 17 Percent

Gen-Probe's clinical diagnostics sales spiked 29 percent to $76.9 million, partially due to products that were gained through last year's acquisitions of Tepnel and Prodesse.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories